Plain-English translation of NCT07682090 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called transcutaneous vagus nerve stimulation (tVNS), which uses a small device placed on your ear to gently stimulate a nerve that helps control pain and your nervous system. Researchers believe this stimulation may help reduce the widespread pain, exhaustion, and nervous system problems that many fibromyalgia patients experience. Half of participants will receive the active treatment, and half will receive a sham (placebo) treatment so researchers can see if the real device actually works.
Current medications and therapies don't work well enough for many fibromyalgia patients. This trial is exploring whether nerve stimulation—a technique that works on a different part of your nervous system than traditional drugs—might offer relief when other treatments fall short.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll visit the clinic once daily for four weeks and receive a 30-minute stimulation session using the small ear device. The stimulation intensity will be adjusted until you feel a mild tingling sensation at the treatment site. You'll follow the same schedule whether you receive active treatment or sham treatment, and you won't know which group you're in until the study ends. Throughout the study, researchers will monitor your pain levels, fatigue, and nervous system function through questionnaires and tests.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Italy